Recombinant Senataxin (SETX) (AA 900-950) anticorps
Aperçu rapide pour Recombinant Senataxin (SETX) (AA 900-950) anticorps (ABIN7453328)
Antigène
Voir toutes Senataxin (SETX) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 900-950
-
Fonction
- Rabbit anti-Senataxin Recombinant Monoclonal Antibody [BLR050F]
-
Immunogène
- between AA 900 and 950
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 6 μL/1 mg lysate
WB: 17:40:00
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- Senataxin (SETX)
-
Autre désignation
- Senataxin
-
Sujet
- Background: Mutations in Senataxin result in the neurodegenerative disorders Ataxia-Oculomotor Apraxia 2 (AOA2) and amyotrophic lateral sclerosis (ALS4). Senataxin bears an RNA/DNA helicase domain suggesting a role in DNA and RNA processing and has recently been found to be involved in the DNA damage response.
-
ID gène
- 23064
-
NCBI Accession
- NP_055861
-
UniProt
- Q7Z333
Antigène
-